WELLINGTON MANAGEMENT GROUP LLP - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,475,195
-21.8%
170,938
-6.2%
0.00%
Q2 2023$1,886,391
+24.0%
182,260
+29.9%
0.00%
Q1 2023$1,521,832
-5.4%
140,261
-2.2%
0.00%
Q4 2022$1,609,307
+4.8%
143,432
-5.3%
0.00%
Q3 2022$1,536,000
+15.0%
151,510
+2.7%
0.00%
Q2 2022$1,336,000
-5.8%
147,468
-0.6%
0.00%
Q1 2022$1,419,000
-35.2%
148,387
-25.1%
0.00%
Q4 2021$2,189,000
+18.2%
198,054
-20.8%
0.00%
Q3 2021$1,852,000
-98.5%
250,219
-97.1%
0.00%
-100.0%
Q2 2021$126,720,000
-16.8%
8,727,324
+16.9%
0.02%
-22.2%
Q1 2021$152,346,000
+56.8%
7,464,202
+36.5%
0.03%
+50.0%
Q4 2020$97,154,000
+39.0%
5,467,300
+15.6%
0.02%
+28.6%
Q3 2020$69,898,000
-25.7%
4,727,592
+5.5%
0.01%
-33.3%
Q2 2020$94,093,000
-2.3%
4,482,777
+7.6%
0.02%
-16.0%
Q1 2020$96,312,000
+17.1%
4,167,523
+31.2%
0.02%
+47.1%
Q4 2019$82,267,000
+1088.8%
3,177,537
+1564.1%
0.02%
+750.0%
Q3 2016$6,920,000190,9500.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$78,677,17613.94%
Irenic Capital Management LP 1,700,937$19,084,5139.15%
Weiss Asset Management LP 7,457,060$83,668,2133.41%
Newtyn Management, LLC 1,450,000$16,269,0003.36%
Palliser Capital (UK) Ltd 97,100$1,089,4622.65%
Chescapmanager LLC 850,988$9,5482.24%
Park West Asset Management LLC 1,920,324$21,546,0352.11%
Baupost Group 11,419,226$128,1242.09%
Saturn V Capital Management LP 141,339$1,334,3421.11%
Oasis Management Co Ltd. 296,960$3,331,8910.66%
View complete list of THERAVANCE BIOPHARMA INC shareholders